References
- Landry O. Notesur la paralysie ascendante gigue. Gazette Hebdomadaire 1859;6:472–4.
- Guillain G, Barré JA, Strohl A. Sur un syndrome de radiculonevrite avec hyperalbuminose du liquide cephalo-rachidien sans reaction cellulaire. Remarques sur les caracteres cliniques et graphiques des reflexes tendineaux. Bull Soc Med Hop Paris 1916;40:1462–70.
- Ito M, Kuwabara S, Odaka M, et al. Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol 2008;255(5):674–82.
- Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956;255(2):57–65.
- Dimachkie M, Barohn R. Guillain-Barré syndrome and variants. Neurol Clin 2013;31(2):491–510.
- Chiba A, Kusunoki S, Obata H, et al. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993;43(10):1911–7.
- Willison HJ, Veitch J, Paterson G, Kennedy PG. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 1993;56(2):204–6.
- Yuki N, Uncini A. Acute and chronic ataxic neuropathies with disialosyl antibodies: a continuous clinical spectrum and a common pathophysiological mechanism. Muscle Nerve 2014;49(5):629–35.
- Yuki N. Guillain–Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey. Proc Jpn Acad Ser B Phys Biol Sci 2012;88(7):299–326.
- Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992;31(6):677–9.
- Mori M, Kuwabara S, Koga M, et al. IgG anti-GQ1b positive acute ataxia without ophthalmoplegia. J Neurol Neurosurg Psychiatry 1999;67(5):668–70.
- Vernino S, Wolfe GI. Antibody testing in peripheral neuropathies. Neurol Clin 2007;25(1):29–46.
- Oyazato Y, Shiihara T, Kusunoki S, et al. A case of anti-GA1 antibody-positive Fisher syndrome with elevated tau protein in cerebrospinal fluid. Brain Dev 2012;34(4):329–32.
- Tomlinson A, Dhakal L, Freeman W. Miller Fisher syndrome from Asialo-GM1 Antibodies: “How can a rare disease become rarer?” Neurology 2015;84(14):Supplement P5.315.
- Koga M, Tatsumoto M, Yuki N, Hirata K. Range of cross reactivity of anti-GM1 IgG antibody in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2001;71(1):123–4.